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Abstract
The aim of the study was to establish 24 month changes in upper limb function using a
revised version of the performance of upper limb test (PUL 2.0) in a large cohort of ambulant
and non-ambulant boys with Duchenne muscular dystrophy and to identify possible trajecto-
ries of progression. Of the 187 patients studied, 87 were ambulant (age range: 7–15.8
years), and 90 non-ambulant (age range: 9.08–24.78). The total scores changed signifi-
cantly over time (p<0.001). Non-ambulant patients had lower total scores at baseline (mean
19.7) when compared to the ambulant ones (mean 38.4). They also had also a bigger
decrease in total scores over 24 months compared to the ambulant boys (4.36 vs 2.07
points). Multivariate model analysis showed that the Performance of Upper Limb changes
reflected the entry level and ambulation status, that were independently associated to the
slope of Performance of Upper Limb changes. This information will be of help both in clinical
practice and at the time of designing clinical trials.
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Introduction
In 2012 an international group of clinicians, physical therapists, patients, advocacy groups and
industries worked together to develop the Performance of the Upper Limb (PUL), a functional
scale specifically designed for assessing upper limb function in Duchenne muscular dystrophy
(DMD) [1–3]. The PUL was designed with the aim of reflecting the proximal to distal progres-
sion of muscle weakness typically observed in DMD. It includes three domains (shoulder,
mid- and distal), each including items exploring activities easily related to activities of daily liv-
ing that both patients and clinicians identified as relevant. The scale was originally designed
using Rasch analysis, a psychometric method that aimed to improve validity and reliability of
the scale. [3]
The scale, in its version labelled 1.2, has been used for over three years and has proved to be
reliable, reproducible and suitable for international multicentric settings [4]. It has also been
found to be related to 6MWT in ambulant patients [5]. In non-ambulant DMD boys has also
been found to be sensitive to changes depending on the steroid regime[6]. Since the original
version of the PUL was published[4], following the acquisition of longitudinal data in a larger
cohort, further clinical testing and Rasch analysis have suggested to modify the scale by delet-
ing redundant items and simplifying the number of scoring, options for most items to 0, 1 or
2; shoulder level items, hands to mouth, tearing paper, trace path, push on light, supination,
pick up coins, number diagram and pinch grip to 0 and 1. This aimed to improve the hierar-
chical response options of individual items within the context of all items. Other items, such as
some shoulder items, moving and stacking light cans and moving heavy cans, key and three
finger pinch items were deleted while one item—moving heavy can diagonally- was added. A
revised scale, PUL 2.0, was therefore proposed with 22 items. The items in the two versions
measure the same construct (PUL 1.2 and 2.0) but the scoring system is different as the PUL
2.0 has scoring options that vary across the scale between 0–1 to 0–2 according to performance
as opposed to the PUL 1.2 that has a broader choice of scoring options (up to 0–5 in some
items) but which were shown to lack clinical distinctiveness.
We report natural history data on a large cohort of DMD boys assessed with the PUL 2.0
for 24 months. The aim of the study was to establish the variability of the results over 24
months in both ambulant and non-ambulant DMD boys and to identify possible trajectories
of progression.
Materials and methods
The study is part of a longitudinal multicentric project aimed at establishing changes in upper
limb function in DMD. Consent was obtained from both adults and parents or guardians of
the minors included in the cohort, all clinical investigation were conducted according to the
principles expressed in the Declaration of Helsinki. The study was approved by the Ethical
Committees of all the participating centers (Catholic University of the Sacred Heart; Univer-
sity of Messina; Bambino Gesu` Children’s Hospital; Second University of Naples; IRCCS Stella
Maris; Istituto Giannina Gaslini; University of Torino; University of Padua; National Neuro-
logical Institute Casimiro Mondino Foundation; IRCCS Institute of Neurological Sciences,
Bellaria Hospital; IRCCS Eugenio Medea; Neurological Institute Carlo Besta; Centro Clinico
Nemo Milan). As part of this, all the Italian tertiary care centers for neuromuscular disorders
consecutively enrolled all the DMD patients attending their routine follow up clinics between
September 2012 and February 2014. The only exclusion criteria were related to the inability to
perform the test because of severe cognitive or behavioral problems.
As in a previous cross sectional study [4] there was an increase of scores in the younger
DMD boys due to a combination of development, increased height and hand size, with an
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obvious slope of deterioration after the age of 7 years, we only included boys> 7 years.
Patients who entered clinical trials were also excluded.
PUL 2.0
The PUL 2.0 includes (S1 figure) an entry item to define the broad starting functional level,
and 22 items subdivided into shoulder level (6 items), mid- level (9 items) and distal level (7
items) dimension[3]. The entry items is based on a revised version of the Brooke score and
ranges from score 0 –no useful hand function—to score 6 full shoulder abduction—no weak-
ness. For weaker patients a low score on the entry item means high level items do not need to
be performed as they would not be achieved.
Each dimension (shoulder, mid-, distal) can be scored separately.
The assessments were performed on forms that allowed to score for both PUL 1.2 and 2.0
but we only report the results for the new version (PUL 2.0).
In the PUL 2.0 there is a maximum score of 12 for the shoulder level, 17 for the mid- level,
and 13 for the distal level. A total score can be achieved by adding the three level scores (max
global score 42). Details of the training sessions and of the reliability studies have already been
reported for the original PUL version[4]. New training sessions were performed for the new
scale with similar level of agreement.
Statistical analysis
Data were analyzed in two ways. First we calculated the PUL 2.0 changes at 12 and 24 months
according to the entry level in both ambulant and non-ambulant DMD boys.
The relationship of the time course of PUL over 24 months, entry level and ambulatory sta-
tus was then analysed using a mixed effect linear model with a random intercept. The model
aims to answer the questions whether the PUL changes significantly over 24 months and
whether the change is different according to entry level, age and ambulatory status (two level
interaction) or according to a combination of these factors (three levels interaction).
The same model was applied to the shoulder, mid- and distal subscores.
Results
One hundred and seventy-seven patients fulfilled the inclusion criteria, 87 were ambulant (age
range: 7–15.8 years, mean: 9.54 (SD: 1.89), median: 9.33) and 90 non ambulant (age range:
9.08–24.78, mean: 16.42 (SD: 3.98), median: 16.25). One hundred and thirty-nine were on ste-
roids and 38 (all non ambulant) were not.
PUL 2.0
The total scores at baseline ranged between 3 and 42 (mean: 28.81 SD: 12.5). The 24 month
changes of the total scores ranged between -21 and +7 (mean -3.23 SD 4.8).
Table 1 and Fig 1 report details of the 12 and 24 month PUL scores subdividing the cohort
into ambulant and non-ambulant.
Changes according to entry level
In the subgroup of ambulant patients 67 of the 87 boys (77%) had an entry item of 6. Their
mean24 month changes were -1.19 in the total PUL scores, of which -0.79 at shoulder level,
-0.19 at mid- and -0.20 at distal level (Fig 2).
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Twenty ambulant boys (23%) had an entry score of 4 or 5. Their mean 24 month changes
were -5 points in the total PUL scores, of which -2.35 at shoulder level, -2.70 at mid- and 0.05
at distal level. None of the ambulant boys had scores lower than 4.
In the subgroup of non-ambulant patients 26 (20%) had an entry level between 6 and 4 and
had the fastest decline. Their mean24 month changes were -8.30 in the total PUL scores of
which -4.04 at shoulder level, -3.58 at mid- and -0.69 at distal level.
Table 1. Details of PUL2.0 scores in ambulant and non ambulant patients at baseline, 12 and 24 months.
PUL 2.0 Baseline 12 months 24 months
TOTAL SCORES Range Mean (SD) Range Mean (SD) Range Mean (SD)
AMBULANT 24–42 38.38 (4.15) 23–42 37.93 (4.47) 19–42 36.31 (6.36)
NON AMBULANT 3–42 19.70 (10.92) 2–40 17.53 (10.05) 2–42 15.34 (8.96)
SHOULDER SCORES Range Mean (SD) Range Mean (SD) Range Mean (SD)
AMBULANT 3–12 9.86 (2.49) 2–12 9.57 (2.62) 2–12 8.71 (3.42)
NON AMBULANT 0–12 2.06 (3.68) 0–12 1.42 (3.14) 0–12 0.9 (2.57)
MID- SCORES Range Mean (SD) Range Mean (SD) Range Mean (SD)
AMBULANT 10–17 16.18 (1.48) 8–17 16.09 (1.79) 6–17 15.41 (2.77)
NON AMBULANT 0–17 7.77 (5.81) 0–17 6.61 (5.59) 0–17 5.355 (4.83)
DISTAL SCORES Range Mean (SD) Range Mean (SD) Range Mean (SD)
AMBULANT 9–13 12.33 (0.92) 10–13 12.26 (0.93) 10–13 12.18 (0.98)
NON AMBULANT 3–13 9.86 (2.55) 2–13 9.50 (2.59) 2–13 9.08 (2.82)
https://doi.org/10.1371/journal.pone.0199223.t001
Fig 1. Mean changes in the total scores and in the three domains in ambulant and non ambulant patients.
https://doi.org/10.1371/journal.pone.0199223.g001
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Twenty-eight (31%) had entry level scores of 3 and 2 and showed an intermediate decline.
Their mean24 month changes were -4.25 in the total PUL scores, of which 0 at shoulder level,
-3.32 at mid- and -0.93 at distal level.
Thirty-six patients (40%) had an entry level of 1 and 0 and showed less decline. Their
mean24 month changes were -1.58 in the total PUL scores of which 0 at shoulder level, -0.86 at
mid- and -0.72 at distal level. Fig 2 reports trajectories of progression based on their entry level
scores.
Using the mixed effect linear model with a random intercept, entry level, age and ambula-
tory status were highly correlated. Ambulant children had a mean age of 9.5 years (SD = 1.9)
and a mean entry level of 5.7 (SD = 0.5); non-ambulant children had a mean age of 16.4 years
(SD = 4.0) and a mean entry level of 2.7 (SD = 1.8), (p<0.001 for both comparisons).
Overall PUL changed significantly over time (mean PUL yearly change -1.5 (SE = 0.18),
p<0.001). The PUL change was significantly associated to entry level (children with entry level
lower than 6 had 1.05 point loss per year more than children with entry level = 6, p = 0.003),
age (children with age higher than the median value of 11.6 years had 0.75 point loss per year
more than children with age lower than 11.6, p = 0.03) and ambulation status (non-ambulant
children having 1.13 point loss per year more than ambulant children, p<0.001), when exam-
ining each factor separately. In a multivariate model, only entry level and ambulation status
resulted independently associated to the slope of PUL change.
In a multivariate model including all the factors, age was no longer significant, while the
ambulation status and the entry levels remains as independent predictors of PUL change over
time. In particular, a 3 levels interaction (time by ambulation status by entry level) was signifi-
cant (p = 0.04), indicating that the difference of time trend between ambulant and non-ambu-
lant children was dependent on entry level.
Discussion
Our 24 month longitudinal data obtained in a large cohort of DMD boys confirmed that the
PUL 2.0 can detect the progression of upper limb involvement, as reported in our previous
study in non-ambulant boys followed longitudinally for 12 months using the previous 1.2 ver-
sion of the PUL [6]. In the present study, using the PUL 2.0 in a wider cohort, including both
ambulant and non-ambulant, the PUL scores changed significantly over 24 months. The range
of changes was quite wide but the variability could be partly reduced when the cohort was
Fig 2. Progression of changes according to entry level scores.
https://doi.org/10.1371/journal.pone.0199223.g002
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subdivided into ambulant and non-ambulant subgroups. The two subgroups had different
baseline scores and different patterns of changes. Ambulant patients had much higher total
scores at baseline when compared to the non-ambulant ones. This largely reflected the fact
that they generally had full or near full scores at shoulder and mid- level that contributed sig-
nificantly to the total score. In these patients, the PUL is often used in combination with other
scales such as the 6 minute walk test. [5] In contrast, in the non-ambulant subgroup, only few
of them had shoulder scores above 4, with the majority having a score of 0.
At mid- and distal level range and mean values were also much lower than in the ambulant
boys but a floor effect could only be consistently observed in the shoulder domain in the non
ambulant patients.
As expected, over 24 months non-ambulant patients showed a bigger decrease in total
scores compared to the ambulant ones (4.36 vs 2.07 points). The pattern of decrease also
largely reflected the baseline scores in the different domains. In the ambulant group the highest
loss was at shoulder level while in the non-ambulant groups was at elbow level as the very low
shoulder scores at baseline in the non-ambulant allowed only a limited decrease.
The variability of changes related to the baseline scores prompted us to further stratify the
cohort according to their entry level item at baseline. This new analysis allowed us to identify
more accurate trajectories of progression in both ambulant and non-ambulant patients.
In ambulant patients, the boys who could complete the entry items, with a score of 6, were
overall stable, with small 24 month changes in the shoulder domain and little or no changes at
mid- and distal level. Ambulant boys with an entry score of 4 or 5 in contrast showed some
changes both at shoulder and mid- level. None of the ambulant boys had scores lower than 4.
The non-ambulant boys with an entry level between 4 and 6 had some residual scores at
shoulder level, that were generally lost over the 24 month observation time, with also a rapid
decrease at mid- level and an overall larger decrease when compared to the other subgroups.
At the other end of the spectrum, those with entry level scores of 0 and 1 already had low
total scores at baseline, and having less activities to be lost, showed small decrease over time.
Patients with intermediate entry level scores (2 and 3) had generally an intermediate decrease
of the total scores mainly related to loss at mid- domain.
Overall, the PUL changes therefore reflected mainly the entry level and ambulation status,
as also proved by multivariate model analysis that showed that both variables resulted indepen-
dently associated to the slope of PUL change.
The results of our study are not easily comparable to our previous findings[6]. This is
because the present study also includes ambulant patients and, more importantly, because of
the different versions of the PUL used. While the items and the activities are almost identical
in the two versions and aim to measure the same construct, the 2.0 version reported in this
study has the advantage of a simplified scoring system which improves it measurement quali-
ties. The new version has also been chosen to provide reference data for several forthcoming
studies.
Our results suggest that the PUL2.0 can be used to follow changes of upper limb function
over time. The scale appears to be more useful to detect shoulder and mid- domain changes
while appears to be less sensitive in patients with function limited to the distal level. Because of
the proximal to distal gradient of progression, however the changes are not linear and a wide
variability can be observed in the whole cohort. The use of the entry levels as stratification cri-
teria allows to identify more precise trajectories and to better define the expected progression
over two years. This information will be valuable at the time of designing new studies or inter-
preting the results of the ongoing trials.
Further studies in larger cohorts are needed to further validate and explore the statistical
properties of the PUL2.0, including the assessment of the Minimal Clinical Important
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Difference (MCID) that was not established in this cohort. Larger studies will also help to
assess if and how contractures affect the level of performance.
Supporting information
S1 File. PUL 2.0 original scoresheet.
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